AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Efiglin-M 500mg/20mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Medopharm

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Efiglin-M 500mg/20mg Tablet ER

Metformin/glimepiride extended-release tablets (500mg/20mg) effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Prescribed either independently or adjunctively with other antidiabetic agents, optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized, considering individual health status, glycemic control, and concurrent medications. Consuming this medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical guidance. Successful blood sugar regulation and complication prevention depend on adherence to both medication and lifestyle recommendations. Commonly reported side effects involve digestive upset (diarrhea, nausea, vomiting) and headaches. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; appropriate recognition and management strategies are essential. Prior to initiating treatment, disclose any pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption to your physician. Similar consultation is necessary for pregnant or lactating individuals. Inform your doctor of all medications to avoid potential interactions. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Regular monitoring of renal function and blood glucose levels will be conducted throughout treatment.

Uses of Efiglin-M 500mg/20mg Tablet ER

Managing type 2 diabetes

Major Benefits of Efiglin-M 500mg/20mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Efiglin-M 500mg/20mg Extended-Release tablets with food.

Common Side effects of Efiglin-M 500mg/20mg Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Efiglin-M 500mg/20mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Efiglin-M 500mg/20mg Extended-Release tablets with food.

How Efiglin-M 500mg/20mg Tablet ER works:

Extended-release Efiglin-M tablets (500mg/20mg) contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Efiglin-M 500mg/20mg extended-release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Efiglin-M 500mg/20mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Efiglin-M 500mg/20mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Efiglin-M 500mg/20mg Extended-Release Tablets on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Efiglin-M 500mg/20mg Extended-Release Tablets. Dosage modification may be necessary; physician consultation is recommended. Efiglin-M 500mg/20mg Extended-Release Tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Extended-release Efiglin-M 500mg/20mg tablets are contraindicated for individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Efiglin-M 500mg/20mg Tablet ER :

Should you forget to take your Efiglin-M 500mg/20mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Efiglin-M 500mg/20mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Efiglin-M 500mg/20mg Tablet ER

Using Efiglin-M 500mg/20mg Tablet ER as directed by your doctor is safe. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia). Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Efiglin-M 500mg/20mg Tablet ER rarely causes hypoglycemia by itself. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Efiglin-M 500mg/20mg Tablet ER may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Efiglin-M 500mg/20mg Tablet ER is contraindicated in patients allergic to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Efiglin-M 500mg/20mg Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect characterized by excessive lactic acid in the blood. This risk is heightened in patients with kidney disease, the elderly, and those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Efiglin-M 500mg/20mg Tablet ER immediately and seek medical attention.
Prolonged use of Efiglin-M 500mg/20mg Extended-Release tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). If you experience these symptoms, consult your physician, who may recommend B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Efiglin-M 500mg/20mg Tabl...
93
MRP 108
13% off